ROZITA DAYANI: Open Payments
NPI 1932706223 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$999 in 17 payments from 10 companies in 2025. Trend: 2023 $131 · 2024 $1,253 · 2025 $999
Food & beverage: $999
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $232 |
| Amgen Inc. | 2 | $142 |
| GlaxoSmithKline, LLC. | 2 | $142 |
| Insulet Corporation | 1 | $129 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $106 |
| SANOFI PASTEUR INC. | 2 | $58 |
| Exact Sciences Corporation | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
Products named: EVENITY, OMNIPOD, PENMENVY, REXULTI, AIRSUPRA, ZEPBOUND, MOUNJARO, VAXELIS.
Industry payments across NM — which companies pay providers there.
